From: Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1
NF1 patients | Healthy controls | P value | |
---|---|---|---|
Total | 138 | 138 | |
Isoform I | 0.00066 ± 0.0001 | 0.0012 ± 0.0007 | 5.47E-06 |
Isoform II | 0.0024 ± 0.001 | 0.01 ± 0.004 | 0.0004 |
Isoform II + I | 0.0029 ± 0.0002 | 0.019 ± 0.003 | 0.0004 |
Isoform II/I | 4.39 ± 1.9 | 4.05 ± 1.3 | 0.5 |
Patients with severe phenotype | Patients with mild phenotype | ||
Total | 36 | 36 | |
Isoform I | 0.0004 ± 0.0001 | 0.0008 ± 0.0001 | 0.002 |
Isoform II | 0.0017 ± 0.0018 | 0.0025 ± 0.001 | 0.09 |
Isoform II + I | 0.0017 ± 0.001 | 0.0029 ± 0.0002 | 0.6 |
Isoform II/I | 5.93 ± 1.7 | 3.92 ± 1.8 | 0.14 |
Patients with LD/MR | Patients without LD/MR | ||
Total | 26 | 45 | |
Isoform I | 0.0004 ± 0.00009 | 0.0007 ± 0.0002 | 0.038 |
Isoform II | 0.0015 ± 0.0005 | 0.0024 ± 0.0008 | 0.11 |
Isoform II + I | 0.0019 ± 0.0003 | 0.0029 ± 0.0005 | 0.09 |
Isoform II/I | 4.92 ± 1.7 | 4.2 ± 1.8 | 0.60 |
Pediatric patients with LD/MR | Pediatric patients without LD/MR | ||
Total | 22 | 31 | |
Isoform I | 0.0001 ± 0.00008 | 0.0007 ± 0.0002 | 0.02 |
Isoform II | 0.0014 ± 0.0004 | 0.0026 ± 0.001 | 0.10 |
Isoform II + I | 0.0015 ± 0.0003 | 0.0029 ± 0.001 | 0.06 |
Isoform II/I | 4 ± 1.4 | 3.72 ± 1.6 | 0.88 |